BNP Paribas Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,536
Closed -$500K 959
2018
Q3
$500K Sell
4,536
-2,585
-36% -$269K ﹤0.01% 794
2018
Q2
$665K Hold
7,121
0.01% 795
2018
Q1
$591K Hold
7,121
0.01% 804
2017
Q4
$649K Buy
7,121
+1,791
+34% +$149K 0.01% 792
2017
Q3
$406K Buy
+5,330
New +$403K ﹤0.01% 847

Other funds holding PRAH

BNP Paribas Asset Management's PRAH Position: Q4 2018 in Review

BNP Paribas Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 4,536 shares — an estimated $500K sold.

BNP Paribas Asset Management first reported a position in PRAH in Q3 2017 and held it in 5 quarters. The position peaked at $665K in Q2 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • BNP Paribas Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • BNP Paribas Asset Management sold 4,536 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $500K.
  • BNP Paribas Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 5 quarters.
  • BNP Paribas Asset Management's PRA Health Sciences, Inc. position peaked at $665K in Q2 2018.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on BNP Paribas Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.